Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1633 1634
This examiner grants 43% of resolved cases
Alexander W Nicol is an examiner in Tech Center 1600 and Art Unit 1633. The examiner has 177 resolved cases. The data shows an allowance rate of 42.9 percent, which indicates the frequency of patent grants for applications in this unit. The median days to allowance for these cases is 1509. This timeframe provides a clear expectation for the duration of the prosecution process.
The interview lift is 43.1 percent. This figure suggests that conducting an interview has a significant impact on the probability of success compared to the 42.9 percent allowance rate. Applicants may find that verbal communication is a highly effective strategy. The 177 resolved cases provide a basis for these observations.
In Art Unit 1633, the 1509 median days to allowance reflects the typical speed of the examination cycle. The 43.1 percent interview lift represents a substantial improvement in outcomes. Practitioners should prioritize an interview when developing their strategy for Tech Center 1600.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18065255 | SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES | Non-Final OA | University of Massachusetts |
| 18628143 | CELL CULTURE MEMBRANE AND CELL CULTURE METHOD | Non-Final OA | TOYODA GOSEI CO., LTD. |
| 18538799 | THERAPEUTIC COMPOSITIONS COMPRISING TRANSCRIPTION FACTORS AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | The Regents of the University of California |
| 18034045 | CONTROLLING CELLULAR BEHAVIOR USING FEED-FORWARD CIRCUITS | Final Rejection | The Regents of the University of California |
| 17169442 | COMPOSITIONS AND METHODS TO BARCODE BACTERIOPHAGE RECEPTORS, AND USES THEREOF | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17152463 | ADENO-ASSOCIATED VIRAL VECTOR, COMPOSITIONS, METHODS OF PROMOTING MUSCLE REGENERATION, AND TREATMENT METHODS | Non-Final OA | NEW YORK UNIVERSITY |
| 17616111 | NOVEL LIVE-CELL ASSAY FOR NEURONAL ACTIVITY | Non-Final OA | UNIVERSITY OF UTAH RESEARCH FOUNDATION |
| 17244136 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18020029 | COMPOSITIONS AND METHODS FOR INCREASING PROTEIN EXPRESSION | Final Rejection | The Hong Kong University of Science and Technology |
| 18282463 | CHARACTERIZING THE BINDING INTERACTIONS BETWEEN MUSK AND BMP RECEPTORS | Final Rejection | Brown University |
| 18252194 | EXPRESSION SYSTEM AND METHOD FOR CONTROLLING A NETWORK IN A CELL AND CELL COMPRISING THE EXPRESSION SYSTEM | Final Rejection | ETH ZURICH |
| 17285148 | CERVICAL CANCER ORGANOIDS | Final Rejection | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
| 18277933 | ADENO-ASSOCIATED VIRUSES AND METHODS AND MATERIALS FOR MAKING AND USING ADENO-ASSOCIATED VIRUSES | Final Rejection | UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| 18737396 | SEQUENTIAL APPLICATION OF MACROPHAGES FOR WOUND HEALING | Non-Final OA | Drexel University |
| 17996759 | OVERCOMING THE TUMOR MICROENVIRONMENT FOR CELL THERAPY BY TARGETING MYELOID DERIVED SUPPRESSOR CELLS THROUGH A TRAIL-R2 SPECIFIC RECEPTOR | Final Rejection | Baylor College of Medicine |
| 17055075 | CRISPR INTERFERENCE BASED HTT ALLELIC SUPPRESSION AND TREATMENT OF HUNTINGTON DISEASE | Final Rejection | THE CHILDREN'S HOSPITAL OF PHILADELPHIA |
| 17283433 | GENERATION OF IMPROVED HUMAN PAH FOR TREATMENT OF SEVERE PKU BY LIVER-DIRECTED GENE REPLACEMENT THERAPY | Final Rejection | Genzyme Corporation |
| 18394085 | CELL PREPARATION METHOD | Final Rejection | KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION |
| 18539379 | MULTI-ORGAN MODEL | Non-Final OA | CELLARTGEN INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy